3・4年次生用 - 東京薬科大学
Contents
1.2.
3.
4. 13 1880 EE
5. DVD
6. SBOs
7. A 1 3 Helicobactor pylori 4 MRSA 5 B
8. 1 2 3 1 4 2 5 3 6 4 7
9. 1 PN on rk ol oo CPNO OR 0 MN D D UT 19
10. G OIOINIO oo Aon SBOs 1 4 6 GCP 1 4 ll 3 4
11. 1 2 3 5 6 8 9 10 1 12 1 1 13
12. SBOs TDM
13. OT OTN OO OO RP MIT DDS 13 14
14. SBOs 1 2 2 1 4 3 1 4 5 1 6 a 7 5 6 8 0 6 7 8 9 6 7 9 10 9 1 10 11 12 1 13 13
15. Dec Rh 1960 1970 3 5 1 2 a 1 3 4
16. 5 Students entering 3 will have the chance to determine their own goals for the year Students in the past have done the following written articles on topics of their choice for TUPLS Times
17. 2 GIO SBOs
18. 1 3 4
19. 34 SBOs 1 1 1 5 2 2 8 g 3 3 10 12 4 1 13 15 5 2 16 17 6 1 18 7 G 19 22 8 23 25 9 26 10 1 27 28 11 28 29 12 30 33 13 34 60 3
20. GIO Ss 1 DNA SBOs DNA 3 DNA 4 DNA 5 6 cDNA DNA 7 POR 8 RNA 9 DNA
21. Sle 1 SBOs 2 3 4 5 6
22. 3 4 5 6 7 8 9 10 SOAP 11 12
23. 2 1 3 2 4 5 1 1 6 1 7 8 9 10 1
24. ola 0 No Nn Rw mM TDM TDM TDM ol DPI EECEEEIEEDTTETEET 3 SBOs
25. H 8 OTC 8 7 4 2 OTC 9 5 OTC 3 1 10 6 OTC
26. 1 6 1 1 1 I
27. 0 10 N10 0 Rw PO OQ oO NN 9 S 3 SBOs 1 2_3 7 2 1 2 3 4 3 1 2 4
28. GIO I 4 2 3 2 3
29. 10 el 1 2 CT MRI 3 4 110 5
30. 1 3 2 4 5 1 1 6 2 2 3 G 1 8 10 1
31. 2 1 A B Evidence Based Medicine EBM
32. CS 3 P gp 1
33. SBOs 1 1_7 9 1 _g 3 a 5_8 4 7 3 5 6 8 DDS 5 10 15 6 DDS 10 15 7
34. TR
35. 3 4 609 124 128 IF DJD 1 130 134 Ui4 I 136 138 140 dng ll 141 J 142
36. 3 1
37. ON IO DPI ST O H O CD H
38. 1 4 8 2 English for Medical Students S Kamiyama et al NAN UN DO Health Care Today T Nishimura et al Asahi Press DID
39. 100 3
40. B
41. 149 I Methods of Teaching Science I 3 2 GIO
42. 3 4 5 6 7 8 9 1 10 11 12 13 ul
43. 1 A 1 1 D B
44. ll 1 3 2 4 5 1 6 3 1 8 9 3 10 hl 12 3 13 1 14
45. 1 SBOs 3 4 5 6 8
46. Ro in situ 2 3 RA 4 5
47. 1 2 3 4 2 8 2 2 2 2 2 1 2 2 2 12 4 a 77 31 C7 2 25 2 4 1 1 Me 2 DO 1 3 2 5 a 1
48. 36d 25 EA 4 6 oe 1 4 2 G 5 1
49. 1 2 SBOs 2 3 4 4
50. constitution um 1 constitutionalism 3 ER 3 4 5
51. 1986 1992 lt 1880 Flore Pharmacia
52. 1 LL j
53. OF 0 0 RP MT CO 1 1 1 13 14 15 16
54. 0 5 ga 1 4 7
55. SBOs 2 3 SBOs 1 2 2 3 4 3 3 4 4 3 4 5 Ps 3 4 6 3 4 2 3 4 8 2 9 3 4 10 SB 1 1 1 RE 12 NIA 13 1 9
56. 1 1 1 P glycoprotein P gp Tight Junction
57. ICD MC ICP MC http www yoshida pharm com text index htmD G04 506 G04 49 6 Diseases and Pharmacotherapy 6 EE 3 1 Cm Cf Pm Pf Bm Bf GIO
58. a Pharmacotherapy 3 GIO 1
59. SBOs lt 2 5 3 1 5 6 4 1 7 1 8 6 9 7 1 9 8 10 9 1 10 PCB 4 10 11 1 10 12 1 1 13 11 14 i 12
60. f 1 a DNA RNA 3 pl ny 4 CH C N DNA 5
61. 3 4 5 6 1 2 38 0 No 0 Rw
62. SBOs 2 3 4 5 6 7 8 9 10 11 SBOs 1 2 GMP
63. 2 3 MENiil AM A
64. 1 B 1
65. 2 324 5 2 253 141 Basic genomics for drug discovery 3
66. 4 Nature CNN 1 B TOEIC TOEFL
67. Fe 4 oh f A 1 3 4 5 6 B
68. Web http www1 ttv nejp ohno nfs Web 505 Microbiology rme 1 Cm Cf Bm Bf Pm Pf
69. SBOs 1 2 1 3 1 4 5 1 6 1 ll 1 2 3 8 ll 1 4 9 1 5 6 10 1 6 1 1 1 6 12 1 6 13 1 7
70. 03 MV Ns A B 1 2 in WO
71. GIO DNA EB SBOs 1 B19 B RNA 2 A C
72. GIO SBOS 1 i O A 8
73. 1 H H
74. AN 7 1 2 3 4 1 2 3 4 1 1 I 1 1 1 1 1 _ 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 HI 1 ZS 6
75. 4 4 2 3 93 24 6 7 8 9 10 1 1 4 E ED E 3 1 2 2 E
76. 1 Michael Mannich Grignard 3 4 5 6 7 8 9 SBOs 1 2
77. 160 0023 G 7 1 o nt Cosmetic Science ea 1 GIO
78. 151 Methods of Teaching Science I 3 4 What is the GIO nature of scientific study
79. 508 IE art illustration 1 1 198 0 9182
80. 9 1 4 a e0000no0ooonooooonooooonodooo 90 92 94 94 94 95 SL jc Pharmacopoeia 3 4 1
81. 4 Hy RY RY Il 1 1 5 3
82. 1716 2 9 i
83. lm 5 Michael Wittig Friedel Crafts t F2a 7 8
84. Te U pH x E 36 SBOs 1 CMC SLS 5
85. 1 104
86. AI FC I Jurisprudence 1 1 Go U
87. t I Medicinal Chemistry I 3 1 Cm Cf Bm Bf Pm Pf aa I GIO SO RN SR Se a SBOs 2 3 4
88. Practice Public and Environmental Health 3 1 GIO SBOs o t
89. Rh Il Science of Traditional Chinese Medicine Prescription 3 1 Pm Pf er
90. 15 00 17 00 15 00 17 00 40 40P Food and Health 3 1 Cm Cf Pm Pf Cm Cf Pm Pf Bm Bf Bm Bf GI0 1 SBOs 2
91. 1 H IGF 7 3 A B A 1
92. i NP Japanese Expression 1 3 1 GIO HH 4 E
93. 1 2 3 J 1 4 147 1
94. lt gt 3 2 55 1 2 5 5 3 2 3 4 125 4 1 3 2
95. A II B RSE drug delivery system DDS DNA siRNA DDS
96. TOEIC i a TOEIC550 TOEIC700 TOEIC TOEFL SBOs NIOIO IO ND
97. 3 3 2 4 5 1 2
98. 6 oll 14 00 17 00 3 14 00 17 00 3 Personalized Medicine 3 1 Cm Cf Bm Bf Pm Pf Evidence based Medicine 0
99. 155 GIO 6 9 I Practice Teaching I 4 3 4 3 4 1 3 3
100. 14 SBOs PCR 1 DNA 7 9 PCH I PCR 1 p450scc PCR 4 I 1 4 8 p450scc 2 3 Sl
101. NY 10 2 57 1 3 2 2 1 2
102. 5 8 1 2 3 9 10 1 2004 3 4 11 15 dB
103. GO 2 B f 100
104. 3 ee 80 5 2 5 9 9 10 3 SM
105. 6 12 00 13 30 304 J McMurry o Cell Technology 3 4 1 GIO 1 R
106. GLP GMP GCP GVP GPSP ICH SBOS i 0 NO oO IQ IN SBOs 1 5 3 GLP 3 5 4 3 9 5 GCP 3 5 6 3 7 GVP GPSP 5 7 8
107. 1 IT 2 9 3 4 5 1 1 2 3 13 14 7 i 1 5F
108. 6 7 8 9 114 SBOs 1 3 4 3 4 4 5 3 4 5 6 7 6 7
109. PH NMR fmol amol elin 1 HPLC
110. SBOs E ee 3 k Lv
111. SBOs 1 2 2 12 3 4 5 6 7 13 3 4 5 6 7 14 1 2 15 25 3 4 5 6 7 26 3 56 7 TOEIC TOEIC Test 1 mm English Conversation 1
112. GBDS 2 3 NSAIDS 5 8 9 10
113. 154 6 Theory of Methods of Student Guidance 3 2 GIO
114. 15 16 17 18 19 Tissue engineering 20 1 23 24 6
115. GIO The ability to speak English is becoming more and more of a necessity for WOrking professionals in Japan The aim of the class is to help students with limited speaking Skills to become more comfortable and more fluent Possible wayS Of learning include using a textbook using and making videos music global issues deDate and DuDliC speaking Class attendance participating speaking in class completion of homework and preparation for discussion will be taken into consideration Each student must have a good dictionary Eric M Skier Donna MclInnis Eric M Skier 5 1S English Conversation English Communication for Science 1 2 GIO The purpose of this English Communication class is to assist students in expanding their scientific vocaDulary thr
116. 1 2 3 4 5 LHR
117. GIO 4 3 4 3 4 3
118. 2 in vitro DM1 TDM TDM 1 1 TDX TDM2 _ 13 138 Experimental Pharmacology 3
119. 1 9 1 1 4 6 9 3 9 1 1 9 10 Rw DO El gl ui 4 6 1 TPN 3 1 6 1 GMP PL 9
120. 12 2 13 f 4 Cosmetic Science 1 Bm Bf GIO
121. 14 8 SBOs 3 3 4 B1 4 5 5 6 Ames 6 7 7 8 9 8 7 8 9 9 10 10 1 11 12 13 1g 14 13 1 14
122. 4 1 2 3 4 OO 1 AN Do EE 000d0000dnooodd0ondodoo 2
123. g 30 SBOs 1 1 3 2 1 4 7 3 1 8 10 4 7 1 11 13 5 2 14 6 ll 15 7 1 16 17 8 1 18 19 9 20 22 10 1 3 23 25 11 4 26 12 1 27 28 13 2 29 30 3 New 4
124. 4 0 gt 4 7 B 1
125. OO OO OO OO 15 00 17 15 00 17 15 00 17 15 00 17 40 40 403 401 SBOs 1 1 a 3 3 5 4 1 2 6 3 5 7 a Si gt 8 12 9 13 0 5 PCB
126. 4 7 1 B 1 3
127. chemical biochemical physicochem GIO ical clinical SBOs technical terms
128. 1 1 1 2 1 9 1 5 2 2 I 1 1 1 5 2 7 3 148 z TH 4 7 Educational Psychology 3 2 ed
129. GIO 1 SBOs 2 3 4 5 6 TDM 7 TDH SBOs 1 1 7 2 1 1 3 3 4 2 1 4 5 5
130. 5 6 7 8 9 SBOs 1 2 1 3 4 3 4 5 5 7 8 8 9 9 10 12 6 13 2 3 304
131. Medicinal Chemistry 2 Chemical Biology 3 Chemical Pharmaceutics Drug Delivery System Drugable 4 A
132. 5 7 MM 8 SBOs w O
133. GIO 1 SBOs 2 3 1 4 H 5 6 Ames 7 8 9 o NOAEL 11 1 12
134. 3 3 er 1 SGD LI 1 3 4 5 SGD
135. CC 3 3 E 2 3 157 2007 19 3 4 192 0392
136. 1 3 3 1 70 1 1 1 2
137. 3 3 di Applied Pharmaceutics 3 1 Cm Cf Pm Pf Bm Bf Cm Cf Pm Pf Bm Bf Cm Cf Pm Pf Bm Bf GIO 3 2 3 1 DDS 3 SBOS
138. CO O CD SBOs 2 3 13 3 4 4 a 5 5
139. 2 508 TO International Relations 2 1 GIO 9 ST 1 SBOs 2
140. SBOs SBOs 2 1 3 1 4 1 2 lt 5
141. 12 13 1 0 NE BB0 1 2 2 1 3 1 4 4 5 7 5 8 9 6 10 1 1 7 12 13 a CO Pn II
142. 30 1 a JR b 2 6 NHK 3 a b gt 100 100 100 100 1 1 000 1 200 1 500 1 1 000 1
143. 3 HIV HTLV 4 5 8 7 EA Se hee A 8 9
144. 1 2 3 8 6 4 9 8 10 5 6 11 13 7 oull
145. 1 16 1883 7 19 1886 21 1888 1 6 22 1889 9 30 1897 11 33 1900 7 6 1917 3 3 1928 11 4 1929 1 6 1931 2 24 1949 2 38 1963 3 39 1964 40 1965 1 3 51 1976
146. 4 5 6 6 8 _ 3 1 8 12 2 3 4 a 13 17 1 2 3 4
147. Pathophysiology 3 0 SBOs 2 3 4 5 6 7 8 9 10
148. B SBOs Introduction and orientation to the Course Classifying Classifying ComDparing ComDparing Cause and Effect Cause and Effect Hypothesizing 1001SNNIOIOIRTOIDOI Hypothesizing Defining Defining Exermplifying Exemplifying and Final Presentations Giving Evidence Giving Evidence Experimenting Experimenting Calculating OOIN OOO RP MN OO Calculating O Reporting O Reporting O O DescriDing 1 1 O CD Predicting 1 IO Predicting and Final Presentations 25 26 Final Presentations Students will be evaluated according to their level of preparation participation and final presentations at the end of each semester English for Science Fran Zimmerman ul 20 1 Vi 1 German 1
149. SBOS f f 001NUIO 1 OTD o 1 1 1 13
150. SBOs 1 3 1 2 4 5 3 6 4 7 4 9 10 1 1 5 11 5 12 6 13 1 6 14 7 2 6
151. o pH OINIOIO RP MT O F I o O CD 14
152. GIO J Re N SBOs
153. _ 9 1 13 17
154. Cm Cf Pm Pf Bm Bf Cm Cf Pm Pf Bm Bf Cm Cf Pm Pf Bm Bf 5 GIO SBOs g
155. lt lt Se NM 2004 3
156. 3 4 HPLC GC MS 1
157. The Cal 4 AlDerts Newton Press 2 6 606 2 6 605 Clinical Immunology 3 1 Cm Cf Bm Bf Pm Pf 4 EE GIO SBOS
158. 3 Evidence based Health Care 2 3 4
159. First in Class Best in Class GCP GMP Pe
160. 13 SBOs 2 2 3 2 4 2 3 4 5 1 3 8 4 7 6 7 8 8 3 4 5 9 3 4 5 10 13 0 12 9 10 13 11 12 15 00 17 00 403 15 00 17 00
161. Ho Chinese 1 2 2 GIO SBOS 1 2 4 5 6 1 1 7 2 2 8 9 3 10 4 3 4 11 5 5 12 1 13 14 6
162. 1 SBos 2 3 4 5 6 7 8 9 SBOs 1 1 j 2 2 8 3 3 1 3 4 4 Te 5 1 4 6 6 2
163. ol IOIN f o i O10 NY 1
164. 7 1 2 3 1 4 2 5 6 7 1 8 2 9 10 11 12 lt English for Proficiency Tests 1
165. i ii 1
166. 001NUIO 1 OIN TD SBOs 2 193 technical terms 14 25
167. http www jsmijp o Pharmacoeconomics EE 3 4 1 GIO 1 SBOs 2 3 4 5 6
168. SBOS 1 2 1 3 5 5 6 6 10 3 4 5 6 11 12 6 7 8 13 3 304 1 Chemistry of Natural Medicines 3 1 Pm Pf Cm Cf Bm Bf Cm Cf Bm Bf GIO SBOS
169. 4 B i A 3 1 B 1 1 f 5 a
170. 1 4 5 6 5 i 6 D gt 7 1 1 1 60 20 2G0 6O 1 316 2 6 4 5 1 3 143 146 1 ES ES 1 je 2
171. sla sns oo No nr ow np SBOs 1 1 3 3 1 4 5 4 6 7 5 3 8 6 1 9 10 7 2 8 3 9 1 3 10 2 4 1 1 1 5 12 5 13 6 14 7
172. 4 H 5 6 7 H 8 9 10 11 12
173. 3 4 5 6 7 WTO 8 SBOs 1 2 3 1 2 4 2 3 2 5 2 3 6 3 4 7 3 4 8 3 4 5 9 SAE 10 4 5 6 1 4 5 6 12 WTO 4 5 6 13 8 14 1 7 15 1
174. 1 5F 2000 1 4 1 2 3 4 i iii 5 6
175. 2 GVH 0 N00 0 R00IM 9 _ 10 11
176. 2 3 a 5 4 SM 5 on i RA
177. IRB OTN 0 R00 MN CRC O 10 C RO 11 S O 1 1001N 7 MO 12 13 6 7 04 G04 4HD Introduction to Medicinal Science 3 1 Pm Pf Pm Pf
178. A in vitro in vivo NMR Mass IR UV X B 1 A
179. A B C 15 D 30 10 E F PHS M
180. 15 00 17 00 40 15 00 17 00 402 15 00 17 00 40 15 00 17 00 403 5 408 402 2 403 403 2 Drug Metabolism amp Molecular Toxicology 3 1 Cm Cf Pm Pf Bm Bf
181. 2 New 4 404 H 3 Diseases and Pharmacotherapy 3 3 1 Cm Cf Pm Pf Bm Bf Cm Cf Pm Pf Bm Bf El
182. HP 505 o 4HT 6 ee Outline of Oriental Medicine 3 4 1
183. A B 1 1 2 3 AGEs
184. 1 a 1 2 1 2 2 2 1 1 ss 2 1 2 3 128 3 130 3 132 IL 3 133 3 134 3 136 3 138 3 140 3 136 3 141 3 136 3 142 3 136 27 4 NE Molecular Toxicology and Environmental Health 3
185. 3 4 A B 1 4 2 3
186. 15 7 16 8 TZ 9 18 10 19 1 1 20 12 2 13 22 14 23 15 24 16 25 17 26 18 27 lt gt lt gt Cs
187. 4 3 55 1980 100 11 56 1981 3 62 1987 8 1 1989 10 4 1992 5 1993 12 gg7 gt 5 12 11 1999 12 15 2003 5 11 17 2005 6 4 18 2006 4 2 6 4
188. 5 6 9 et st 1 2 10 ER 11 14 RE 2 1 5F 15
189. 10 11 12 13 SBOs 1 1 4 3 H 8 4 5 1 6 2 7
190. 2 3 4 5 6 7 8 9 10 11 12
191. I I I I I 0 1
192. SBOs 1 4 3 4 2 3 4 5 6 2 3 4 7 8 3 4 9 10 3 4 11 1 2 3 4 13 14 2 3 4 1 15 17 Sa 18 19 2 3 4 20 21 3 3 4 22 24 2 3 4 25 26 2 3 4 27
193. 13 NSAID 14 15 16 NSAID SAID SAID 17 18 19 20 21 23 24 25 6
194. 27 28 29 30 31 SBOs NO 0 RR WIM TD CO 00 Vv 3
195. 1 1 2 3 5 6 9 Woodward Hoffmann 10 11 12 O
196. 19 3 4 1 3
197. 11 SBOs de 2 1 6 3 11 4 11 5 1 11 1 3 2 6 2 6 eo ye II
198. 134 SBOs 1 7 8 9 12 2 SOAPIc lt S9 10 1 1 3 1 4 4 5 3 5 6 6 7 1 12 2 a m 135 Pha
199. 30 1 126 186 14 53 49 116 6 4 10 20 57 49 126 lt
200. 12 13 14 15 SBOs 1 3 4 3 5 4 6 5 7 6 1 8 7 2 8 8 1 1 W 9 9 8 9 10 10 11 11 2 12 12 13 14 13
201. Ca TRH GnRH CRH PIH GnRH GnHH FSH LH ADH PTH SU SU 11 12
202. Cm Cf Pm Pf Bm Bf Cm Cf Pm Pf Bm Bf 0 SBOs NODIOI IDImDI
203. 9 10 11 12 SBOs 1 18 3 Tx G7 4 3 5 10 1 5 3 5 8 12 6 1 6 8 12 7 4 5 10 12 8 4 5 10 12 9 i 4 8 12 10 4 8 12 11 3 5 6 10 18 1 3 5 6 10 1 13 T
204. 9 1 Pharmacology 3 a
205. 6 H 28 H 29 30 31 3 SBOs 1 2 11 12 1 2 3
206. 1 3 MRSA MRSA Ds RE 8 MP Pe B a OO A 2
207. 30 31 33 34 PRTR 35 36 37 38 SBOs I 1 2 3 5 51 POPs
208. SBOs 2 3 4 5 6 7 SBOs p p 5 p p 1 A 6
209. o Synthetic Organic Chemistry 3 4 1 GIO SBOs 305 p Ka
210. 13 14 15 SBOs 1 1 2 3 3 3 2 3 4 1 4 5 5 2 6 7 6 3 8 9 7 4 10 11 8 5
211. 14 15 SBOs a DNA ob
212. 6 1 DDS 1 siRNA SiRNA DNA 3 A B
213. 1 HMG CoA 3 4 OS Eric M Skier
214. 13 14 15 16 17 18 19 20 21 22 SBBOs 1 1 2 2 3 3
215. 5 6 6 5 6 7 7 8 5 8 9 ll 9 0 10 13 10 13 2 10 11 3 7 10 11 1 4 12 13 1 1 1 f wl Dispensing Pharmacy 3 1
216. 16 20 15 20 5 158 An Introduction to Counseling in School 3 _ GIO
217. 2 8 4 3 5 7 4 4 8 10 1 5 11 13 6 O 13_16 7 3 15 16 8 4 18 5 1 pH 9 pKa pH
218. Pharmacy Administration 3 1 QOL EH 4 1
219. 14 3 15 2 9 00 12 OO Histopathology 3 4 1 GIO 7 EE SBOs 3 4 5 6 7 8 9 10 1 7 1 13 7
220. Contemporary Economics 2 1 GIO 1 SBOs 2 3 4 5 6 7 8
221. o 14 PC B 15 16 18
222. 8 1 9 10 11 12 1 13 14 3 15 2 9 00 12 00 3 4 70 71 72 74 ee 75 pp 76 ere 77 ti 78 ee 80 pp 82 pp 84 ee 86 ese 87
223. C 3 1 4 7 1 8 ll 3 9 4 r 10 1 1 5 6 7 12 13 8 9 1 Structural Theory of Organic Chemistry 3 ee 3 1 EPE GIO
224. lt Medicinal Chemistry I a 3 1 Cm Cf Bm Bf Pm Pf 1 GIO SBOs Diels Aldder
225. 1 17 30 19 00 504 ll Pharmacology II 3 1 Bm Bf Bm Bf Bm Bf GIO
226. 1432 1 TEL 042 676 5892 6
227. U ea French 1 2 GIO SBOs 2 3 1 5 6
228. 3 4 1 1 5 G 7 5 1 1 2 1 1
229. GIO OTC OTC I OTC 3 4 gt _ OTC 1 1 2 3 O 7 OTC
230. 2 3 3 8 4 3 8 5 3 8 6 3 8 7 y 4 8 8 5 6 8 9 7 8 10 A 11 8 9 12 I 10 11 13 H 10 11 9 2 7
231. 7 8 9 10 1 12 13 2 SBOs 3 0 1 2 4 6 1 etre SS Tr 9 2 avoir ls 5 T2r M3 10 12 3 er ir 1 2 6 12 13 13 14 15 18 4 aller faire Jy 8 SN MSN 19 22 5 1 2 10 12 13 23 26 8 SSRSNe 13 27 a rt a
232. Cm Cf Pm Pf Bm Bf GIO H medicine UU lt 4 Patient friendly
233. 1 2 6 1 2 7 Tp 8 Lx 9 1 2 10 1 2 11 3 12 3 6 13 3 L2007 8 gt Inter
234. 5_6 2 DM 1 TDM 5 6 Population Pharmacokinetics 2 8 8 9 7 4 8 9 10 5 8 9 11 ll 6 8 9 12 11 13 5 6 10 B096 14 00 17 00 Pharmaceutical 1echnology 3 1 Cm Cf Pm Pf Bm Bf
235. A A CCO since 1880 2007 3 4 19 Tokyo University of Pharmacy and Life Sciences Department of Clinical Pharmacy Men s Division Department of Pharmaceutical Science Department of Biopharmaceutical Science School of Pharmacy Department of Clinical Pharmacy Women s Division Department of Pharmaceutical Tokyo University of Pharmacy and Life Scicnces Graduate School Science Department of Biopharmaceutical Science Graduate Course in Pharmaceutical Sciences Graduate School in Pharmacy Graduate Course in Clinical Pharmacy M S Course M S Course Ph D Course 2007 19 3 4 BT x since 1880
236. Eee 3 4 1 Go E
237. 6 2 Fi 2 1 1 1 I 1 1 1 I 1 1 1 1 1 2 1 2 1 2 1 2 1 1 1 1 1 1 1 1 3 1 1 4 1 1 5 1 1 6 1 1 1 1 1 1 1 1 1 I 1 1 1 1 2 1 1 1 1
238. 4 1 2 4 2 HH 2 ey II br 3 4 1 2 gaaa 2 1 2 1 9 2 2 3 4 6 10 2 pe 7 1 AM A II
239. Cm GIO Cm Cm Cf Pm Pf Bm Of Pm Pf Bm Bf Bf Cf Pm Pf Bm Bf i SBOs 1
240. DE DRC 3 Science of Clinical Traditional Chinese Medicine EE 3 1 Cm Cf GIO
241. TOEIC 1 3 1 2 1 1 8 1
242. 146 2 4 3 4 5 Dy 1 2 3 4
243. Pharmaceutical Affairs Law 3 1 GIO Cm Cf Pm Pf Bm Bf Cm Cf Pm Pf Bm Bf SBOS DO NO 0 OTD
244. cm Cf Pm Pf Bm Bf Cm Cf Pm Pf Bm Bf GIO SBOS
245. 12 13 9 1 1 14 15 10 2 2 14 15 11 3 1 14 15 12 4 2 14 15 13 5 14 15 14 14 15 4 URL http Www nihs gO jp dig jindex html 14 00 17 00 14 00 17 00 14 00 17 00 3 3 2 08 5 Diseases and Pharmacotherapy 5 1
246. 3 A B C D E 80 C 2 5 4 3 2 1 9 2 3
247. 3 4 PML XML 5 1300 3 GDPSD 6 CYP 1
248. 6 34 IP 1
249. 6 1 1 3 4 5 6 A B
250. DDI A 1 jn Vo vivo 2 3 B 1 55 2
251. 403 403 403 Environmental health rm 1 Pm Pf Bm Bf GIO Cm Cf RI a SBOs
252. B B A A gt ll 1
253. Cm Cf Pm Pf Bm Bf SBOs E
254. N CC 0 9 3 4 4 1 2 3 5 20 22 I 23 355556550550555505655005 24 DD OO OO leleleTo eele 26 OOOOOGQGOOOOQGOOOGQGOOOOQGOOOO 28 OGGQGOO GOQCOOGOQGOOOGQOGO Oo 30 OOGQGOOOGQCOOOOQGOOGGQGOOOG 32
255. 19 19 2 4 2 4 3 4 5 6 9 8 10 5 1 2 18 5 19 1 24 6 6 20 7 17 18 30 8 1 9 15 8 5 8 18 9 3 1 3 4 10 1 3 15 _ 9 17 10 11 12 17 18 24 3 5 6 28 3 6
256. 20 21 25 23 24 25 a 27
257. 3 B A 1 MMP ADAM TS 2 i fh 3
258. SBOs 1 2 1 2 1 2 1 2 1 2 SBOs LT O10 NO OO RK PM OIOINIO OIRQOIN O00 NO OO OR RI 0 WIN OR ow MN O
259. 1 Cm Cf Pm Pf Cm Cf Pm Pf GIO HI GPCR SBOs
260. 3 4 3 5 4 7 8 5 7 6 7 8 7 8 9 9 10 10 1 1 1 1 12 12 13 D 13 14 15 1 9
261. 5 6 ei 2 1 3 jp 3 1 2 6 17 3 18 4 13 14 Ww 15 6 1 2 3 4 mn
262. dd000000000000000000D0000G0000 34 oooooooQooQOoooooo 36 38 EC 40 He 42 3 oo56G9G5G9Oo95Goo0Qo 44 4 46 5 OOoOOOOOQOOOOOOOOOOOO 48 6 BSISYoYofcicYefoforofofoxotoforciccoio 50 IO ea le loess feele eats loze 52 5 54 QGOOGGQGOOGGQOOOGOOGOOOOQOOO O 56 COOGOOGOOGOOCOOQOOOOOOOO5O 58 oGOOooOoOOQbOGOOqoooo 60 62 63 64 66 67 68 Se EE Practical English for Pharmacy 3 2
263. OTC 1 0TC 1 6 3 4 5 OTC 1 4 39 4 5 6 OTC 1 1 5 3 Ea 4 5 6 OTC 6 7 2 OTC 3
264. 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 3 1 4 1 eR 5 1 1 6 1 1 1 1 1 1 2 1 1 1 1 1 1 1 PE 1 gt NV 1 i 1 1
265. 11 18 3 I 6 11 18 4 7 es 5 8 11 18 1 2 9 11 6 a 1 2 11 1 Be 4ILINUL 7 i 8 1 10 18 9 1 10 19 20 1 22 23 24 2 a 25 26 27 12 28 2g 30 13 20 29 831 1 3 3
266. SBOs 2 3 4 5 6 7 8 9 10 11 12 SBOs 1 7 2 1
267. g 15 lt Diagnosis of Iraditional Chinese Medicine EN 3 1 Bm Bf
268. 1 1 25 20 1 7 GO 8 1 15 16 17 21 31 4 12 26 1 5 1 3 2 8 18 18 8 1 3 1 G 3 19 1 3
269. 4 5 4 6 5 7 6 8 7 9 10 8 11 9 12 10 13 14 1 1 15 16 12 17 13 18 19 14 20 22 I 3 8 Pharmaceutical Development amp Production 3 4 1 GIO C
270. DDS 16 17 8 7 18 19 Tissue ngineering 9 20 10 11 22 24 1 55 6 13 1 26 8 1 3 1 3 2 3
271. 1 1 1 1 1 1 1 9 1 1 1 1 I 1 1 1 L 1 1 1 1 2 1 1 14 o 1 ie 1 H 1 1 a 1 1 9 I 1 1 1 I 1 I 1 1 14 1 1 1 ee 2 1 1 16 8
272. 1 7 2 OTO 12 8 OTC 13 9 OTC 14 oO 15 OTC OTC 3 DOS 16 Drug Oriented System 1 OTC Case Study 17 2 18 OTC OTC
273. 2007 1 9 NR EAE ER NT RN 3 TE A EP A 4 O ep EE A SE OE A Op PE 5 ee reed RI ERNE ORT EE RR TRI 6 9 3 SI 20 To 22 23 ERT EER NSE ERA 24 Oo 26 ET IE RRR RE TR ERE TEN EEE RE 28 I PT ER RN RN 30 TE TRAIN TIARA NS 32 CC ERR RR SR RR hs 34 36 NN NE RC EE A 38 SR 98208 40 VT TE YE EE RS 42 3 ARETE ERNE RR 44 4 PT EAR NI ENR IE 46 5 CRRA RD RR 48 6 EP TO Te PP SA 50 RNR NE RN Nhs 52 Si dp RG RA RS Pe 54 PA PAIR NR RR ENN REN RT 56 NINE NR ENR ER EER 58 PY REI A 60 RT 1 62 EN EY EO PCP PE PE 63 eee ae eo es 64
274. MD oO 0 NO OR WM SBOs 1 2 m Hiro 0 NTO 0 RR 0M CO f
275. ol 0O J 00 O E O O O O O OO IO 1H
276. 1 B A Human Biology 1 pl Ii adil 1 3 4 4 1
277. 7 8 9 10 i EG SN NN TS 30 31 32 7 2 8 x 35 36 37 38 14 15 16 17 3 9 11 18 19 20 38 CS rk 3 4 1 3 13 26 27 28 29 2005 2005 1 401 Pharmacology II Ss 3
278. 1 1 12 13 pm fo Clinical Trial 3 1 Cm Cf Cm Cf GIO SBOs I II
279. 3 1 1 4 1 5 1 6 1 PE 1 I 2 1 I 2 1 1 2 1 pe es 2 1 Pe PE 3 1 Pe Psy 1 1 1 2 1 3 1 1 2 6 1 2 1 7 i 1 2 3 10
280. B HU B Ames OHNO 0 RR O H 10 11 1 12 13
281. a 15 16 2 17 18 3 I Practice II Medical Pharmacy 3 4 1 0 1 SBOs 2 3
282. 17 18 19 0 D0 BOD COD 21 23 24 26 28 29
283. 1 2 3 1 4 2 6 2 7 3 8 4 9 5 Se 10 See 11 12 13 14 15 16 3 1825
284. 4 5 6 7 8 4 5 6 7 9 2 6 7 10 12 8 13 lt 2UWC 2 9 1 V 1 2 8 LS Ni Philosophy 1 2 1
285. fF 3 1 A 1 B f
286. 1 DDS m DDS DDS a DDS A 3
287. 18 0 6 10 18 1 3 I in vitro 11 18 22 24 4 12 1 18 22 24 13 CC Practical Pharmacy 3
288. 3 NININIO OO S 8 DNA 2 RNA 1 3 RNA lS Ralrp lo O00 No nk olm 3 60 f 3 Topley amp Wilson H s Microbiology and Microbial Infections 9ed 506 1 E Nutrition 3 1 Dl GIO
289. 7 6 1 7 140 gt 3 5 Medicinal Chemistry 3 6 1
290. 3 1 2 3 4 5 6 7 8 9
291. 3 4 5 6 7 8 9 PCB 12
292. GMP 4 5 9 ICH 4 5 1 6 12 8 13 8 8 2 3 6 3 M 14 00 15 10 V 15 20 16 30 M 16 40 17 50 Es 4 11 V V 3 4 5 9 WV V 5 6 5 24 V V 7 10 530 V V 11 8 9 6
293. 50 12 15 1 2 3 4 5 6 V 1 00 5 00 1 2 3 DVD
294. 9 SBOs 1 1 2 ll 3 1 3 4 2 3 4 5 3 4 5 6 3 5 7 3 4 5 8 4 5 6 9 4 5 6 10 4 5 6 1 4 5 6 12 4 5 6 13 MSA 5 6 7 14 5 6 7 oll
295. GIO ll 3 1 4 2 5 7 1 6 7 7 3 8 9 ll 2 10 3 11 ll 1 12 13 7 3 14 ll 15 ll Clinical Medicine
296. 7 8 3 1 7 8 4 1 7 9 5 1 7 9 6 1 7 10 12 0 2WCZ _7 10_12 1 12 Oe a II Practice of Pharmaceutical Information 3
297. OF OIO RP MT O O CD ol SBOs 1
298. Yl 1 Biotechnology 3 1 Pm Pf Cm Cf Bm Bf I I GIO
299. an original 3 publication visited Yokota Air Force Base for gone to observe pharmacy education at UCSF and pharmacy practice in America and improved their TOEIC scores If students have new ideas they will be seriously considered as improving students English and communication skills in real life situations is the primary goal of the laDoratory TO meet the above goals students will De exposed to English teaching that will require them to think critically Since this may be a challenge the use of Japanese for academic writing and COnversations on global health isSsues will be allowed These conversations will be held in both classroom and informal settings such as lunch and dinner Dartie8 TO accomplish the aforementioned goal any range Of sources may De COnsulted for instance magazines Time and Newsweek and movies Bowling for Columbine Students will eventually have the chance to focus on One of the issues raised throughout the year in order to write a final paper exploring In depth the causes ramifications and possible solutions 06 gt 4
300. SBOS ll Cm Cf Pm Pf Bm Bf
301. aE OT 66 A RNA EIN EYE Rs 67 HRC 68 3 4 1 OP TE RO RT ER TS 70 1 EE YK 71 RRNA RAIA RNN GRR EA ARENA 72 ET DP 74 TO a RS 75 RR NE XOXO 76 Be PO ep OE Te UE AUT EE Ee Ee Poe 77 78 80 RR ERNE RRR RE RR 82 RR RR RR RN ME ye 84 RAIN SN RR a a 86 PE RRR OO AR OE EE PRA 87 SS Eee 88 4 es 90 Pe eR Oe Fe WH CE EU oT et re PAR RT 92 94 RR NT 68657 6 Ph 94 RIRS NRE EN SR 94 CE 95 1 8 110 RR EE CO YA PP EO NR RR Ce AD 111 dh a a ER 112 113 I EA OR A A ERA 114 rt dD 1 16 A a a a 117 i NR EE RIE ER I
302. 0 ing Sei Methods of Teaching Science I h 3 2 Pa 4 GIO
303. 4 6 7 3 4 6 8 0 4 4 6 9 1 ZS9 10 2 9 11 3 9 12 4 9 13 5 9 6 604 2 6 604 2 2 2 J 4 Diseases and Pharmacotherapy 4 EE 3 1
304. 6 MW V VI TS 3 4 V V INonprescription Drugs 3 4 1 aa
305. EER 1 18 ee 119 I CN Pe i YD A YB ey ER 121 CE eS EE EN I CE PE ga 5Cetedgi 122 A 123 128 I 0 130 I NO ep 132 I RRR RRR 133 I TEI RE ES EES ENR EE tt 134 136 138 140 141 142 Oe 146 149 1 150 151 ee 152 ee ee 154 PE MEET OE Ey POT A dt 155 Ls 156 So 157 007
306. SHR 156 PR ll Practice Teaching II 4 2
307. nship 3 8 1 GIO 8 9 3 6 7 5
308. ough the use of the text as well as supplementary materials The focus will be on communication in English utiliz ing the discussion points related to each unit Group discussions will be an integral Component as well as individual presentations Dased on topics stu dents select from the discussion DOIntS SBOs Classifying The Composition of Matter discussion topic how classifica tions may De used Comparing The Elements discussion topic COmparing Contrasting In 2 general and in science 3 Cause and Effect discussion topic determining Cause and effect now and in the future 4 Hypothesizing discussion topic forming a hypothesis about issues In our lives 5 Defining Energy discussion topic scientific definition vs creative defini tion 6 Exemplifying Heat discussion topic how examples help to clarify and SUD port 7 Giving Evidence discussion topic offering evidence to support an opinion 8 Experimenting discussion topic giving directions to complete a proce dure g Calculating Liquids and Gases discussion topic using calculation as a tool in science 10 Reporting discussion DOint reporting on a recent event in a newspaper or magazine grticle ll Describing The Universe discussion topic using precise descriptions 12 Predicting The Weather discussion topic making predictions about the st century Td mm
309. rmaceutics 3 HLB
Download Pdf Manuals
Related Search